We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Laura Elizabeth Lansdowne

Laura Elizabeth Lansdowne

Managing Editor

 at Technology Networks

As managing editor, Laura works with the associate editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She oversees the in-house editorial team and works directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.

Got a question for Laura Elizabeth Lansdowne?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 400
Ocular Fibrosis, 3D Cell Culture Image, spherical microscopy image with various colors.
Industry Insight

Bridging Academia and Industry: The Evolution of 3D Models in Drug Development

The industry's search for alternatives to traditional preclinical drug testing methods has led to a growing interest in the potential of three-dimensional (3D) in vitro models. To delve deeper into this subject, Technology Networks spoke with Madhu Lal-Nag, chief scientific officer at InSphero, a 3D in vitro model company with a mission to “modernize drug discovery in ways that inspire researchers everywhere to reach their full potential and fuel a new era of breakthrough therapies.”
Rendered image of cells.

Cell Therapy: Clinical Applications, Manufacturing and Regulation

Download this listicle to learn more about the applications of cell therapy, the regulatory landscape of cell therapy, and manufacturing and scalability challenges.
Three scientists positioned around a globe and labware, with various icons symbolizing sustainable science.
Industry Insight

Supporting Sustainable Biopharmaceutical Production With Plant-Based Plastic Labware

Encouraging scientists to rethink the materials and methods they use will help to foster a culture of sustainability within research institutions and across various industries. Technology Networks spoke with Dr. Joel Eichmann from Green Elephant Biotech to learn more about the creation of its plant-based plastic labware, and his broader vision for embedding sustainability within the biotech industry.
A globe sitting among leaves
Industry Insight

Global Sustainability: Lab Goals, Actions and Measuring Success

Scientists around the world are increasingly aware of the environmental footprint of their laboratories, and many are adjusting the way they work day-to-day to offset this impact. In this Industry Insights interview, Agilent's Dr. Michael Frank discusses the safety and efficiency considerations that are fundamentally linked to sustainability and considers why more labs aren’t utilizing consulting services to help them achieve their sustainability goals.
Spatial Transcriptomics in Cancer content piece image

Spatial Transcriptomics in Cancer

In this infographic, we explore spatial transcriptomics and how progress in this area is paving the way to a better understanding of cancer.
High-Throughput Screening content piece image

High-Throughput Screening

Download this infographic to explore key milestones and assay types, innovations driving high-throughput screening (HTS) and a typical HTS workflow.
Cancer Genetics content piece image

Cancer Genetics

In this infographic, we delve into the field of cancer genetics, highlight key milestones and explore how genomic approaches are transforming diagnosis and treatment of the disease in the clinic.
Rewiring T Cells To Enhance Immunotherapy Efficacy content piece image

Rewiring T Cells To Enhance Immunotherapy Efficacy

Researchers have identified a modifier gene called lymphotoxin beta receptor (LTBR) – which is not normally expressed in T cells – and combined it with CARs to create T cells that were better equipped at killing tumor cells.
Cancer Research Horizons: Driving Innovation and Strengthening Academia–Industry Collaboration content piece image
Industry Insight

Cancer Research Horizons: Driving Innovation and Strengthening Academia–Industry Collaboration

In April 2022, Cancer Research UK unveiled Cancer Research Horizons, its new approach to driving innovation in the field. Technology Networks had the opportunity to speak with two members of Cancer Research Horizon’s executive leadership team to learn more about some of the cutting-edge experimental capabilities that will be used to interrogate cancer biology more thoroughly.
Opinionated Science Episode 43: Genomics Power Hour: Decoding Morning Sickness and Dog Behavior content piece image

Opinionated Science Episode 43: Genomics Power Hour: Decoding Morning Sickness and Dog Behavior

In this episode of Opinionated Science, the team reviews two studies that show off the power of genomic technologies, from very different angles. One answers key questions about why some women experience extreme vomiting and sickness during pregnancy, and the other reveals why dog breeds aren’t all they are cracked up to be.